Z Squared completes business combination with Coeptis Therapeutics Apr 24, 2026 04:47PM
Vanderbilt Report: Coeptis / Z Squared Merger Enters Final Stretch - Closing Imminent as Institutional Tailwinds Build Mar 9, 2026 08:07AM
Coeptis receives shareholder approval for Z Squared merger Feb 5, 2026 04:02PM
Vanderbilt Report: Coeptis Therapeutics Shareholders Approve Transformational Merger: From Biopharma to Dual-Sector Platform Feb 4, 2026 04:15AM
Coeptis Therapeutics details $835M merger structure with Z-Squared Jan 6, 2026 08:33AM


Jan 6, 2026 08:31AM Coeptis Therapeutic Holdings Details $835M Transaction Structure with Z-Squared; Vanderbilt Report Publishes Coverage
Jul 22, 2025 08:36AM Coeptis extinguishes convertible note debt with YA II PN
May 28, 2025 08:28AM Coeptis Therapeutics (COEP): Monarch Therapeutics and SNAP Biosciences Enter Licensing Agreement to Bolster SNAP-CAR NK Cell Therapy in Oncology
May 12, 2025 08:20AM Nuburu (BURU) Files $100M SEC Registration Statement
Apr 28, 2025 01:35PM SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Coeptis Therapeutics Holdings, Inc. Merger
Apr 25, 2025 08:38AM Coeptis Therapeutics (COEP) and Z Squared Inc. Announce Merger Agreement
Apr 17, 2025 08:39AM Coeptis (COEP) partners with NexGenAI and Ishvara to launch tech hub in India
Apr 15, 2025 08:33AM Nuburu (BURU) Announces Strategic Corporate Update Focused on Defense & Security, Advanced Technologies, and Growth Initiatives
Apr 4, 2025 06:25AM Coeptis Therapeutics (COEP) files for 3.92M Share Offering by Selling Stockholders
Mar 11, 2025 08:35AM Coeptis Therapeutics (COEP) Secures Worldwide Development and Commercialization Rights to Next-Generation GEAR Cell Therapy Platform
Mar 7, 2025 08:38AM COEPTIS’ (COEP) NexGenAI Affiliates Partners with NUBURU (BURU) Network to Drive Innovation in AI and Robotics as Part of its Transformation Plan
Feb 19, 2025 04:00PM Coeptis Therapeutics (COEP) NexGenAI Affiliates Network & MarketLeverage Announce Strategic Partnership to Revolutionize AI-Powered Affiliate Marketing
Feb 13, 2025 08:39AM Coeptis Therapeutics (COEP) Launches COEP Venture Group
Jan 30, 2025 08:27AM Coeptis Therapeutics (COEP) Becomes COEPTIS: Embracing a Future of Technology and Innovation
Jan 23, 2025 08:11AM Coeptis Therapeutics (COEP) Leverages Artificial Intelligence and Blockchain for Next-Generation Innovation
Jan 7, 2025 08:04AM Coeptis Therapeutics (COEP) Announces First Customer Adoptions of its NexGenAI Marketing Platform
Dec 27, 2024 08:15AM Coeptis Therapeutics (COEP) Announces 1:20 Reverse Share Split
Dec 26, 2024 08:16AM Coeptis Therapeutics (COEP) Acquires NexGenAI Affiliates Network, Launches Coeptis Technologies
Dec 12, 2024 08:01AM Coeptis Therapeutics (COEP) Unveils New Technology Division: Coeptis Technologies
Dec 3, 2024 08:16AM Coeptis Therapeutics (COEP) to Acquire NexGenAI Affiliates Network
Oct 24, 2024 08:07AM Coeptis Therapeutics (COEP) Expands License Agreement with Deverra to Include Pandemic Preparedness, and Emergency Use
Sep 19, 2024 07:07AM Coeptis Therapeutics (COEP) Regains Nasdaq Complianc
Sep 5, 2024 08:08AM Coeptis Therapeutics (COEP) Chief Executive Officer, Dave Mehalick, Updates and Outlines Strategic Vision in Letter to Shareholders
Jun 17, 2024 02:03PM Ladenburg Thalmann Downgrades Coeptis Therapeutics Holdings, Inc. (COEP) to Neutral